Boston-based Haemonetics announces intent to acquire OpSens in healthtech deal worth $345 million CAD
Posted in General

H|T: The Healthtech Times – AI takeover: predictive pitfall or “medicine’s biggest moment” since antibiotics?

Plus: Quebec City-based OpSens acquired by US firm in $345M deal. The Healthtech Times is a weekly newsletter covering healthtech news from Canada and…

Continue Reading H|T: The Healthtech Times – AI takeover: predictive pitfall or “medicine’s biggest moment” since antibiotics?
First VCCI inclusive growth stream recipients get funding as Quantum Industry Canada appoints first-ever CEO
Posted in General

First VCCI inclusive growth stream recipients get funding as Quantum Industry Canada appoints first-ever CEO

Plus: Exploring the forgotten history of Canadian venture capital. Welcome to BetaKit’s startup stories of the week! Here, you will find the week’s most…

Continue Reading First VCCI inclusive growth stream recipients get funding as Quantum Industry Canada appoints first-ever CEO
Boston-based Haemonetics announces intent to acquire OpSens in healthtech deal worth $345 million CAD
Posted in General

Boston-based Haemonetics announces intent to acquire OpSens in healthtech deal worth $345 million CAD

OpSens said acquisition will provide the company with a global sales channel. A duo of healthtech firms have announced an agreement in which Boston-based…

Continue Reading Boston-based Haemonetics announces intent to acquire OpSens in healthtech deal worth $345 million CAD